Developing a new treatment device: How to get an idea to the marketplace

A good idea does not inevitably lead to successful innovation; it needs additional “drivers” and coherent activity of a specialized team. The initial idea needs proof‐of‐concept and prototype testing. Alongside, market review must anticipate future need and competitors, and ensure that no current pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurourology and urodynamics 2012-04, Vol.31 (4), p.429-436
Hauptverfasser: Dymond, Elizabeth, Long, Adele, McCarthy, Avril, Drake, Marcus J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 436
container_issue 4
container_start_page 429
container_title Neurourology and urodynamics
container_volume 31
creator Dymond, Elizabeth
Long, Adele
McCarthy, Avril
Drake, Marcus J.
description A good idea does not inevitably lead to successful innovation; it needs additional “drivers” and coherent activity of a specialized team. The initial idea needs proof‐of‐concept and prototype testing. Alongside, market review must anticipate future need and competitors, and ensure that no current patents are infringed. The likelihood that reimbursement will be secured and that health systems will “adopt” the device has to be considered. Intellectual property (IP) protection is needed to maintain sole rights to exploit the core concept. Non‐disclosure agreements (NDA) should be put in place, and commercial considerations should be remembered before any disclosure in the public domain, including publications. Prospective business partners will review the concept from many perspectives, including stage of device development, effective IP protection, any clinical trial evidence, and whether the device aligns with their business strategy. Royalties arising from sales of a marketed device are distributed to all parties contributing to its development; the party bearing the greater financial burden of developing the final product will gain the greater share of royalties. The innovator's employer will have a call on proceeds if the idea arose in the course of employment. All stages of development require fastidious documentation to meet requirements of the regulatory authorities responsible for permitting use in patients. Specific regulatory requirements depend on which region(s) of the world the device will be marketed in. This review explains all stages of the innovation pathway from concept to adoption, giving practical advice and signposting expertise relevant to each stage. Neurourol. Urodynam. 31:429–436, 2012. © 2011 Wiley Periodicals, Inc.
doi_str_mv 10.1002/nau.21141
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1008824545</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1008824545</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3631-3783f85aac6ea99fe9ce3e95dd5e4067c1fc15dbc9de0a9c1e3b340c9302e3ba3</originalsourceid><addsrcrecordid>eNp1kF1PwjAUhhujEUQv_AOml3oxaNd1Xb1DVDBBTAxE75rSneF0bHMdIP_eIh93Xp2PPOfNyYPQJSVtSojfyfWi7VMa0CPUpNwnXiiEOEZNIhjz_CAUDXRm7SchJGKBPEUNn0rCSSSaaHAPS8iKMs1nWOMcVriuQNdzyGscwzI1cIsHhdsWeAY11jlOY9Cbsf4APNfVF9Rlpg2co5NEZxYudrWFJo8P497AG770n3rdoWdYyKjHRMSSiGttQtBSJiANMJA8jjkEJBSGJobyeGpkDERLQ4FNWUCMZMR3rWYtdL3NLaviewG2VvPUGsgynUOxsMoJiSI_4AF36M0WNVVhbQWJKqvUvbx20IbzlROn_sQ59moXu5jOIT6Qe1MO6GyBVZrB-v8kNepO9pHe9iK1NfwcLpwyFQomuHob9dXdMx1Hr-9SCfYLZxKGBQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1008824545</pqid></control><display><type>article</type><title>Developing a new treatment device: How to get an idea to the marketplace</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Dymond, Elizabeth ; Long, Adele ; McCarthy, Avril ; Drake, Marcus J.</creator><creatorcontrib>Dymond, Elizabeth ; Long, Adele ; McCarthy, Avril ; Drake, Marcus J.</creatorcontrib><description>A good idea does not inevitably lead to successful innovation; it needs additional “drivers” and coherent activity of a specialized team. The initial idea needs proof‐of‐concept and prototype testing. Alongside, market review must anticipate future need and competitors, and ensure that no current patents are infringed. The likelihood that reimbursement will be secured and that health systems will “adopt” the device has to be considered. Intellectual property (IP) protection is needed to maintain sole rights to exploit the core concept. Non‐disclosure agreements (NDA) should be put in place, and commercial considerations should be remembered before any disclosure in the public domain, including publications. Prospective business partners will review the concept from many perspectives, including stage of device development, effective IP protection, any clinical trial evidence, and whether the device aligns with their business strategy. Royalties arising from sales of a marketed device are distributed to all parties contributing to its development; the party bearing the greater financial burden of developing the final product will gain the greater share of royalties. The innovator's employer will have a call on proceeds if the idea arose in the course of employment. All stages of development require fastidious documentation to meet requirements of the regulatory authorities responsible for permitting use in patients. Specific regulatory requirements depend on which region(s) of the world the device will be marketed in. This review explains all stages of the innovation pathway from concept to adoption, giving practical advice and signposting expertise relevant to each stage. Neurourol. Urodynam. 31:429–436, 2012. © 2011 Wiley Periodicals, Inc.</description><identifier>ISSN: 0733-2467</identifier><identifier>EISSN: 1520-6777</identifier><identifier>DOI: 10.1002/nau.21141</identifier><identifier>PMID: 21905087</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>device ; Diffusion of Innovation ; Equipment and Supplies ; Humans ; innovation ; Intellectual Property ; intervention ; market ; technology</subject><ispartof>Neurourology and urodynamics, 2012-04, Vol.31 (4), p.429-436</ispartof><rights>Copyright © 2011 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3631-3783f85aac6ea99fe9ce3e95dd5e4067c1fc15dbc9de0a9c1e3b340c9302e3ba3</citedby><cites>FETCH-LOGICAL-c3631-3783f85aac6ea99fe9ce3e95dd5e4067c1fc15dbc9de0a9c1e3b340c9302e3ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fnau.21141$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fnau.21141$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21905087$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dymond, Elizabeth</creatorcontrib><creatorcontrib>Long, Adele</creatorcontrib><creatorcontrib>McCarthy, Avril</creatorcontrib><creatorcontrib>Drake, Marcus J.</creatorcontrib><title>Developing a new treatment device: How to get an idea to the marketplace</title><title>Neurourology and urodynamics</title><addtitle>Neurourol. Urodyn</addtitle><description>A good idea does not inevitably lead to successful innovation; it needs additional “drivers” and coherent activity of a specialized team. The initial idea needs proof‐of‐concept and prototype testing. Alongside, market review must anticipate future need and competitors, and ensure that no current patents are infringed. The likelihood that reimbursement will be secured and that health systems will “adopt” the device has to be considered. Intellectual property (IP) protection is needed to maintain sole rights to exploit the core concept. Non‐disclosure agreements (NDA) should be put in place, and commercial considerations should be remembered before any disclosure in the public domain, including publications. Prospective business partners will review the concept from many perspectives, including stage of device development, effective IP protection, any clinical trial evidence, and whether the device aligns with their business strategy. Royalties arising from sales of a marketed device are distributed to all parties contributing to its development; the party bearing the greater financial burden of developing the final product will gain the greater share of royalties. The innovator's employer will have a call on proceeds if the idea arose in the course of employment. All stages of development require fastidious documentation to meet requirements of the regulatory authorities responsible for permitting use in patients. Specific regulatory requirements depend on which region(s) of the world the device will be marketed in. This review explains all stages of the innovation pathway from concept to adoption, giving practical advice and signposting expertise relevant to each stage. Neurourol. Urodynam. 31:429–436, 2012. © 2011 Wiley Periodicals, Inc.</description><subject>device</subject><subject>Diffusion of Innovation</subject><subject>Equipment and Supplies</subject><subject>Humans</subject><subject>innovation</subject><subject>Intellectual Property</subject><subject>intervention</subject><subject>market</subject><subject>technology</subject><issn>0733-2467</issn><issn>1520-6777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kF1PwjAUhhujEUQv_AOml3oxaNd1Xb1DVDBBTAxE75rSneF0bHMdIP_eIh93Xp2PPOfNyYPQJSVtSojfyfWi7VMa0CPUpNwnXiiEOEZNIhjz_CAUDXRm7SchJGKBPEUNn0rCSSSaaHAPS8iKMs1nWOMcVriuQNdzyGscwzI1cIsHhdsWeAY11jlOY9Cbsf4APNfVF9Rlpg2co5NEZxYudrWFJo8P497AG770n3rdoWdYyKjHRMSSiGttQtBSJiANMJA8jjkEJBSGJobyeGpkDERLQ4FNWUCMZMR3rWYtdL3NLaviewG2VvPUGsgynUOxsMoJiSI_4AF36M0WNVVhbQWJKqvUvbx20IbzlROn_sQ59moXu5jOIT6Qe1MO6GyBVZrB-v8kNepO9pHe9iK1NfwcLpwyFQomuHob9dXdMx1Hr-9SCfYLZxKGBQ</recordid><startdate>201204</startdate><enddate>201204</enddate><creator>Dymond, Elizabeth</creator><creator>Long, Adele</creator><creator>McCarthy, Avril</creator><creator>Drake, Marcus J.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201204</creationdate><title>Developing a new treatment device: How to get an idea to the marketplace</title><author>Dymond, Elizabeth ; Long, Adele ; McCarthy, Avril ; Drake, Marcus J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3631-3783f85aac6ea99fe9ce3e95dd5e4067c1fc15dbc9de0a9c1e3b340c9302e3ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>device</topic><topic>Diffusion of Innovation</topic><topic>Equipment and Supplies</topic><topic>Humans</topic><topic>innovation</topic><topic>Intellectual Property</topic><topic>intervention</topic><topic>market</topic><topic>technology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dymond, Elizabeth</creatorcontrib><creatorcontrib>Long, Adele</creatorcontrib><creatorcontrib>McCarthy, Avril</creatorcontrib><creatorcontrib>Drake, Marcus J.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neurourology and urodynamics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dymond, Elizabeth</au><au>Long, Adele</au><au>McCarthy, Avril</au><au>Drake, Marcus J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Developing a new treatment device: How to get an idea to the marketplace</atitle><jtitle>Neurourology and urodynamics</jtitle><addtitle>Neurourol. Urodyn</addtitle><date>2012-04</date><risdate>2012</risdate><volume>31</volume><issue>4</issue><spage>429</spage><epage>436</epage><pages>429-436</pages><issn>0733-2467</issn><eissn>1520-6777</eissn><abstract>A good idea does not inevitably lead to successful innovation; it needs additional “drivers” and coherent activity of a specialized team. The initial idea needs proof‐of‐concept and prototype testing. Alongside, market review must anticipate future need and competitors, and ensure that no current patents are infringed. The likelihood that reimbursement will be secured and that health systems will “adopt” the device has to be considered. Intellectual property (IP) protection is needed to maintain sole rights to exploit the core concept. Non‐disclosure agreements (NDA) should be put in place, and commercial considerations should be remembered before any disclosure in the public domain, including publications. Prospective business partners will review the concept from many perspectives, including stage of device development, effective IP protection, any clinical trial evidence, and whether the device aligns with their business strategy. Royalties arising from sales of a marketed device are distributed to all parties contributing to its development; the party bearing the greater financial burden of developing the final product will gain the greater share of royalties. The innovator's employer will have a call on proceeds if the idea arose in the course of employment. All stages of development require fastidious documentation to meet requirements of the regulatory authorities responsible for permitting use in patients. Specific regulatory requirements depend on which region(s) of the world the device will be marketed in. This review explains all stages of the innovation pathway from concept to adoption, giving practical advice and signposting expertise relevant to each stage. Neurourol. Urodynam. 31:429–436, 2012. © 2011 Wiley Periodicals, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>21905087</pmid><doi>10.1002/nau.21141</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0733-2467
ispartof Neurourology and urodynamics, 2012-04, Vol.31 (4), p.429-436
issn 0733-2467
1520-6777
language eng
recordid cdi_proquest_miscellaneous_1008824545
source MEDLINE; Access via Wiley Online Library
subjects device
Diffusion of Innovation
Equipment and Supplies
Humans
innovation
Intellectual Property
intervention
market
technology
title Developing a new treatment device: How to get an idea to the marketplace
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A08%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Developing%20a%20new%20treatment%20device:%20How%20to%20get%20an%20idea%20to%20the%20marketplace&rft.jtitle=Neurourology%20and%20urodynamics&rft.au=Dymond,%20Elizabeth&rft.date=2012-04&rft.volume=31&rft.issue=4&rft.spage=429&rft.epage=436&rft.pages=429-436&rft.issn=0733-2467&rft.eissn=1520-6777&rft_id=info:doi/10.1002/nau.21141&rft_dat=%3Cproquest_cross%3E1008824545%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1008824545&rft_id=info:pmid/21905087&rfr_iscdi=true